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Abstract 
 
Tae1 is an amidase produced by gram negative Pseudomonas bacteria that 
attacks the peptidoglycan layer in the cell walls of neighboring bacteria after secretion 
through the Type VI secretion system (T6S).  The goal of our work is mapping 
interactions between the type-VI-secretion system effector Tae1 and its putative 
substrates using nuclear magnetic resonance (NMR) spectroscopy.  Tae1 is amenable to 
NMR in that we are able to collect spectra with resolved, well defined peaks that can be 
assigned, thereby providing valuable structural information.  We have assigned 89.2% of 
backbone atoms and 87.4% of sidechain atoms.   Assignment of Tae1 was performed 
with 15N-HSQC, HNCA, HNCOCA, HNCACB, CBCACONH, HCCH COSY, HCCH TOCSY, and 
HCONH TOCSY experiments.   Peptidoglycan binding experiments were performed using 
via 15N-HSQC to monitor backbone residues and 13C-HSQC to monitor sidechain 
residues.  So far, these experiments have not revealed the molecular mechanism by 
which Tae1 recognizes its specific substrate; however, with the very high degree of 
assignment achieved in NMR experimentation, once a minimal binding fragment has 
been isolated determination of the binding mechanism will be easily achieved. 
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With multi-drug resistant bacteria becoming more and more prevalent, we can 
no longer rely on well-established antibiotics to treat life-threatening bacterial 
infections.  As pathogenic bacteria have become resistant to humanity’s primary 
defense against them, a detailed understanding of resistance in pathogenic bacteria is 
an imperative.  Among the most important research to be done currently is the 
development of new antibiotics so that resistant infections can be treated successfully 
(Taneja et al. 2016).  Research regarding potential targets for novel antibiotics is focused 
on conserved structures unique to bacteria that are necessary for their survival.  One of 
the most conserved and critical structures ubiquitous throughout the bacterial kingdom 
is the bacterial cell wall (Kuhner et al. 2014).   
The bacterial cellular envelope is composed of the plasma membrane and the 
cell wall; it is the bacterium’s first line of defense against threats it encounters in its 
environment.   The bacterial envelope was viewed until the 1950’s as a simple self-
assembling semipermeable sack around the cell (Silhavy et al. 2010).  We now know 
that the bacterial cellular envelope is a complex and varied structure that requires a 
significant investment of energy to assemble and maintain (Brown et al. 2013).   
The cellular envelope must protect the bacterium from its hostile and often 
rapidly changing environment, while still allowing selective transport of nutrients into 
the cytosol (Silhavy et al. 2010).  Investigation into the bacterial cellular envelope led to 
the development of the famous Gram staining technique (Taneja et al. 2016).  There are 
two major classes of bacterial cellular envelopes characterized by the Gram stain: gram 
2 
 
positive, and gram negative (Figure 1).  Gram positive bacteria such as S. aureus have an 
inner membrane surrounded by a thick layer of peptidoglycan (PG) composing the 
bacterial cell wall. In contrast, gram negative bacteria, such as E. coli, have a much 
thinner peptidoglycan cell wall but a second protective membrane outside of the 
peptidoglycan layer (Gan et al. 2008).  The entire PG layer with the proteins and 
remaining cellular components removed is known as the bacterial sacculus.  The 
sacculus is a gigadalton-large, highly dynamic, heterogeneous structure, which has 
proven difficult to characterize structurally (Schanda et al. 2014).  While the 
composition of the peptidoglycan wall is well-characterized through electron 
cryotomography and atomic-force microscopy, protein-peptidoglycan, and 
peptidoglycan interaction with antibiotics have been difficult to elucidate (Schanda et al. 
2014). 
 
Simplified structure of Gram+/Gram- Cellular Envelopes 
Figure 1: Simplified structure of Gram +/Gram – cells.  Image Available at: 
http://www.sigmaaldrich.com/technical-
documents/articles/biology/glycobiology/peptidoglycans.html.  
 
The peptidoglycan cell wall is the prokaryotic cell’s molecular coat of armor.  As 
shown in Figure 2, it is a rigid structure with a backbone composed of repeating 
alternating units of the monosaccharides N-acetyl glucosamine (GlcNAc) and N-acetyl 
muramic acid (MurNAc) with a network of cross-linked peptides extending from the 
glycan backbone (Gan et al. 2008).  Positions of the crosslinks can vary among bacterial 
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species but in general are conserved within a particular species (Silhavy et al. 2010).  The 
rigid peptidoglycan cell wall makes up a single macromolecule surrounding the cell 
(Romaniuk et al. 2015).  The cell wall provides structural support for the cell, creates the 
characteristic shapes of many bacteria, and confers resistance to turgor pressure (Chou 
et al. 2012).  That prokaryotic cells do not lyse in a dilute solution such as distilled water 
is mediated, in the greatest part, by the peptidoglycan cell wall (Silhavy et al. 2010).   
 
Molecular structure of peptidoglycan 
Figure 2: Structure of peptidoglycan.  Image modified from American Society for 
Microbiology.  Original available at: 
http://cmr.asm.org/content/18/3/521/F2.expansion.html. Accessed October 18, 2014.   
 
As the cell wall is rigid, a cell must break down and reform the peptidoglycan for 
growth and division.  The maintenance of the peptidoglycan cell wall is an energy 
intensive process. Formation is a multistep mechanism where pentapeptide precursors 
are formed within the cytosol, and must be exported to the outside of the cell (Gan et 
al. 2008).  These precursors are generally excreted at a small inlet of the cell wall known 
as the septum (Typas et al. 2012).  Once they are excreted they are covalently bound to 
the GlcNAc/MurNAc by specific enzymes.  Maintenance, in terms of peptidoglycan 
breakdown is a process which is carried out by a host of “housekeeping enzymes” (Chou 
et al. 2012).  Among these housekeeping enzymes are amidases which catalyze the 
breakdown of peptidoglycan, and penicillin binding proteins which are necessary for 
catalyzing the cross-linking of new peptidoglycan (Chou et al. 2012). 
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Because PG is only observed in prokaryotes it makes a desirable target with 
reduced risk to eukaryotic cells.  Many of modern medicine’s frontline antibiotics 
already target PG (Kuner et al. 2014).  For instance, penicillin targets one of the proteins 
responsible for the maintenance of the peptidoglycan layer (Otero et al. 2013).  
Penicillin and its derivatives like methicillin are known as β-lactam antibiotics due to 
their bicyclic ring structure, as shown in Figure 3, and inhibit one of the proteins which 
reforms the peptidoglycan known as penicillin binding protein (Otero et al. 2013).  
When the cell can no longer maintain its cell wall it will lyse and die.   
 
Figure 3: Structures of Beta lactam antibiotics 
Within the last 60 years the detailed analysis of the structure of PG has been 
attempted by various methods (Kühner et al. 2014).  Because of peptidoglycan’s 
immense size and inherent flexibility, PG does not crystallize for X-ray diffraction 
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imaging methods, and is only amenable to NMR solution-state experiments with 
muropeptide fragments or solid-state NMR investigation (Desmarais et al. 2014; 
Schanda et al. 2014).  To date the most effective methods of probing PG structure have 
been the application of liquid chromatography to analyze muropeptide fragments, and 
electron microscopy of whole sacculi (Kühner et al. 2014).  These techniques are limited 
to providing information on bulk PG structure, and crosslinking of the peptides. They 
cannot provide atomic-level detail to protein/PG interactions (Schanda et al. 2014).   
High pressure liquid chromatography and ultra-pressure liquid chromatography 
(HPLC/UPLC) methods carried out on muropeptides has proven useful in characterizing 
the structure of peptidoglycan crosslinks (Desmarais et al. 2014).  Muropeptides are 
fragments of peptidoglycan consisting of peptides of various lengths bound to N-
acetylmuramic acid generated from enzymatic digestion of the PG into disaccharides 
(Kühner et al. 2014).  As they are a substantially smaller size than the intact bacterial 
sacculi they can also be utilized in experimental investigations of substrate binding to 
PG-modifying enzymes (Kuhner et al. 2014).   
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Figure 4: HPLC analysis of muropeptide fragments after digestion with Tae4 and Tae3 as 
well as a control displaying all possible fragments.  See “Figure 4a”  Russell et al., 2012, 
“A Widespread Bacterial Type VI Secretion Effector Superfamily Identified Using a 
Heuristic Approach;” Cell Host and Microbe 11: 538–549. 
 
Substrate cleavage specificity studies are performed by treating intact bacterial 
sacculi with the enzyme of interest, and subsequently treating the resulting reaction 
mixture with an enzyme to digest (and thereby remove) the glycan strand.  The 
remaining peptide fragments are then analyzed by HPLC/UPLC (Figure 4) to elucidate 
the site at which the enzyme of study is cleaving the PG (Kuhner et al. 2014).  If no PG 
cleavage is performed by the enzyme of interest one would observe PG fragments of the 
same distribution as simply treating with lysozyme or muramidase.  Furthermore, if the 
PG degrading enzyme of interest is promiscuous in its cleavage one would observe a 
broad distribution of muropeptide fragments.  Thus, observing reproducible 
distributions of muropeptide fragments following double-digestion leads directly to the 
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identification of characteristic cleavage sites for the PG hydrolase of interest.  While co-
crystallization of proteins, with their cognate substrate is the most definitive method for 
determining protein substrate interactions, no structures of this class of amidase bound 
to substrate have been reported.    Because co-crystallization has proven difficult, in 
silico docking methods have been utilized to propose potential protein/PG interactions 
(Chou et al. 2012).  Thus, muropeptides have proven to be of limited use for binding 
assays (Mellroth et al. 2014). 
Our long-term goal is to elucidate the molecular details of PG binding by PG 
amidases, and thereby contribute to the understanding of the antibiotic action of this 
class of enzymes. The current work was carried out on the toxic amidase effector 1 
(Tae1) from Pseudomonas aeruginosa.  While bacterial cells employ several 
“housekeeping” amidases that are responsible for remodeling the PG for bacterial cell 
growth, they are highly regulated (to prevent toxicity) and have very closed or occluded 
active sites (Figure 5) making structural imaging of these enzymes with PG substrates  
difficult (Chou et al. 2012).  
Pseudomonas aeruginosa engages in interbacterial “chemical warfare” using a 
secretion system known as Type Six Secretion (T6S) to deliver toxic effectors to 
neighboring bacterial cells, thereby providing it a significant competitive advantage 
(Russell et al. 2011). 
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Figure 5: X-ray crystal structures of closest structural homologs "housekeeping" PG 
amidases and Tae1. Catalytic cysteines are highlighted in yellow, and regulatory regions 
are highlighted in red.  PDB entries 3H41, 3PBI, 2K1H, and 4F4M respectively.  Note the 
active-site-proximal regulatory region of the non-toxic amidase YkfC (red).  Further, it 
can be seen that RipB contains an N-terminal extension (red) and Spr has catalytic-site 
adjacent residues that occlude their substrate binding sites relative to that of the toxin 
Tae1. See “Figure 2A” from Chou et al 2012, “Structure of a Peptidoglycan Amidase 
Effector Targeted to Gram-Negative Bacteria by the Type VI Secretion System”, Cell Rep. 
2012; 1(6):656-64. 
 
As shown in Figure 6, type six secretion (T6S) in P. aeruginosa cell requires the 
assembly of a long actin filament tubule akin to a bacterial sex pilus (Russell et al. 2011).  
Upon contact with a neighboring cell the tubule is rapidly shot out of the host cell 
piercing the neighboring cell like a hypodermic needle (Russell et al. 2011).  A host of 
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toxic effectors are then injected through the T6S assembly (Russell et al. 2012).  These 
toxic effectors are delivered via direct translocation through the phage-like apparatus 
(Russell et al. 2011).   
 
Figure 6: Cartoon representation of type six secretion with host cell piercing outer 
membrane of neighboring cell and injecting toxic effects. See “Figure 1” from Russell, et 
al (2014) “Type VI secretion effectors: poisons with a purpose” Nature Rev. Microbiol. 12: 
137-148.  
 
In addition to addressing questions of the mechanism of the effectors 
themselves, we hope to understand how the effectors are localized to the T6S and 
thereby secreted.  Given the variety of proteins in the cytoplasm, how do secretion 
systems such as T6S discriminate between them and exclusively bind and secrete the 
appropriate effectors? Such substrate specificity might be mediated by several factors 
including signal sequences, chaperones, and receptors (Silverman et al. 2013). 
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Studies by the Mougous lab at UW Microbiology implicated the ring structured 
haemolysin coregulated protein 1 (Hcp1) in the localization and excretion of the type six 
secretion system effectors (Silverman et al. 2013).  While initially thought of as a “static 
conduit” through which effectors of the T6S would pass, Hcp1 was shown to have a 
significant impact on both the cytoplasmic concentration of the toxic type six secretion 
effector 2 (Tse2) and its excretion (Silverman et al. 2013).  To perform studies on the 
export of effector proteins the ∆retS mutation was incorporated which results in the 
excretion of effectors directly into the supernatant (Silverman et al. 2013).  By doing 
this, effectors and cofactors necessary for excretion could be identified. 
When Hcp1 is knocked out, the effectors Tae1, Tse2, and Tae3 are not found in 
the supernatant in measurable quantity (Silverman et al. 2013).  Along with full gene 
knockout, structural mutations that effect the internal binding residues, such as the 
S115Q mutation, stop exportation of the toxic effectors (Silverman et al. 2013). Further 
investigation utilizing transmission electron microscopy (TEM) found that Tse2 was 
found localized and bound within the Hcp1 ring structure (Figure 7; Silverman et al. 
2013).  While it was not explicitly shown that Tae1 and Tae3 were bound within the 
Hcp1 ring, the secretion data cited above, and TEM findings of Tse2 bound to Hcp1 
suggested that Tae1 binds with Hcp1 and is thereby exported through the T6S 
(Silverman et al. 2013). Thus, we performed NMR titration experiments with 15N-labeled 
Tae1 and unlabeled Hcp1 in an attempt to identify the contacts between the two 
proteins. 
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Figure 7: TEM images of Hcp1 showing the distribution of class averages in a sample of 
3,000 randomly selected particles with 72% unfilled, 23% filled; additionally displayed is 
a control of Hcp1 not incubated with Type six secretion effector 2( Tse2), displaying that 
the filled particles are indeed bound with Tse2. See “Figure 3D” from Silverman et al 
2013 “Haemolysin Coregulated Protein Is an Exported Receptor and Chaperone of Type 
VI Secretion Substrates,” Annu. Rev. Microbiol. 2012; 66: 453-72.   
 
Tae1 and Tae3 have been shown to be lytic enzymes with Tae1 breaking down 
the crosslinked peptide region of the peptidoglycan and Tae3 showing muramidase 
activity, cleaving between the glycans in the PG backbone (Chou et al. 2012).  These 
peptidoglycan hydrolases were found through a heuristic investigation to be part of a 
superfamily of toxic effectors which cluster into conserved branches, each with a 
distinct PG cleavage specificity (Figures 8 and 9; Russell et al. 2012).     
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Figure 8: Type six secretion amidase effectors can be broken into 4 family groups 
distinguished by their peptidoglycan cleavage specificity. See “Figure 3C” from Russell et 
al 2012 “A Widespread Bacterial Type VI Secretion Effector Superfamily Identified Using 
a Heuristic Approach,” Cell Host Microbe. 2012; 11(5): 538-49.  
 
 
Figure 9: Sites of PG cleavage by the distinct amidase families. The color coding is the 
same as in Figure 8. Tips of color coded triangles point to scissile bond within the PG. See 
“Figure 4B” from Russell et al 2012 “A Widespread Bacterial Type VI secretion Effector 
Superfamily Identified Using a Heuristic Approach,” Cell Host Microbe. 2012; 11(5): 538-
49. 
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The observation of conserved cleavage specificities is intriguing given their roles 
as toxins.  More promiscuous cleavage would, in principle, inflict greater damage to the 
cell wall target.  The PG substrates needed to determine the observed cleavage 
specificities are obtained from bacterial saccule. First bacterial peptidoglycan sacculi are 
extracted from the rest of the bacterial cell by breaking apart the primary cell 
components with a bead beater, followed by sedimentation of the cell walls with high 
speed centrifugation, then enzymatic digestion of the remaining non-peptidoglycan 
elements with RNase, DNase, and Trypsin.  Extracted sacculi are then treated with the 
given effector amidase followed by a glycan-degrading muramidase so that the 
remaining muropeptide fragments can be analyzed by HPLC-MS to determine where in 
the PG amidase directed hydrolysis occurs as seen in Figure 10 (Russell et al. 2012).  Due 
to the difficulty of working with whole PG sacculi, digesting the PG macromolecule into 
muropeptides for further investigation is necessary for structural or binding studies 
(Kühner et al. 2014) 
Tae1 was found to be specific for cleavage of the γ-D-glutamyl-L-meso-
diaminopimelic acid (D-glu-m-dap) bond, indicated by the green arrowheads in Figure 
10 (Chou et al. 2012).  By the HPLC-MS experiments displayed in Figure 10 one can 
observe that PG fragment products obtained after double digestion of sacculi with Tae1 
followed by muramidase define a high cleavage specificity of Tae1 for the D-glu-mDap 
bond. Given this cleavage specificity, B. subtilis was used as the bacterium of choice for 
the isolation sacculi to be used as a test substrate for probing the details of Tae1 binding 
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to PG. B. subtilis is a well-studied gram positive bacterium, and its PG layer contains the 
necessary (D-glu-m-dap) bond.   
 
Figure 10:  HPLC chromatograms of PG sacculus treated with the muramidase cellosyl 
(top) and PG sacculus treated with Tae1 followed by cellosyl (bottom). See “Figure 4A” 
from Chou et al 2012 “Structure of a Peptidoglycan Amidase Effector Targeted to Gram-
Negative Bacteria by the Type VI Secretion System,” Cell Rep. 2012; 1(6):656-64.  
 
The crystal structure of Tae1 has been solved to 2.6 Å resolution (Figure 11; 
Chou et al. 2012).  As seen in Figure 11 the active site is very open, suggesting multiple 
orientations of PG are possible. Attempts to co-crystallize various PG substrates with 
Tae1 have not yet yielded crystals that diffract (Chou et al. 2012, Shang et al. 2012). 
Docking studies performed in silico using MacroModel 9.9 to scan the structural face of 
Tae1 with an L-Ala-D-Glu-mDAP PG fragment did not converge on a common bound 
conformation in the catalytic pocket of Tae1, but rather, returned 168 unique 
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conformations with 20 of them sharing the highest score from the Glide XP function 
(Chou et al. 2012). Thus, while the specific site of cleavage within the peptidoglycan and 
the structure of Tae1 are known explicitly, the interactions that determine the cleavage 
specificity of Tae1 remain unknown.  
This prompted us to ask whether solution-state Nuclear Magnetic Resonance 
spectroscopy (NMR) might reveal the molecular features of Tae1 that lead to the 
observed cleavage specificity. 
 
Figure 11:  Tae1 crystal structure a fragment of PG modeled in the binding cleft in one 
possible conformation within the active site.  Catalytic residues Cys30 and His91 labeled 
yellow and red respectively. 
 
For proteins the relationship between structure and function is well-established 
thanks to the molecular-level insights provided by X-ray crystallography and NMR 
(Ziarek et al. 2011).  X-ray crystallography is the gold standard for protein structure 
determination, however it has multiple limitations.  Its greatest limitation is the 
necessity of crystallization of the protein and substrate (Williamson et al. 2013).  To 
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analyze the structure of proteins in solution NMR is the superior technique.  NMR is 
limited in its application by the size of the analyte. At ~ 17kDa, Tae1 at it is well within 
the range of molecular weights for which NMR is tractable (Cavanagh et al. 2010).   
NMR relies on the nuclear spin of atoms with odd mass numbers in that such 
nuclei have magnetic moments.  Within a strong external magnetic field (B0) the nuclear 
magnetic moments will align with that of B0.  Nuclear magnetic moments exhibit Larmor 
precession around the axis of the external magnetic field as shown in Figure 12.  The 
greater the strength of B0 the higher the frequency of the precession.   
 
Figure 12:  Larmor precession of nuclear spins in an external magnetic field.   
 
The Larmor precession of the individual nuclear spins in the protein cannot be 
observed directly (Cavanagh et al. 2010).  The individual precessing magnetic moments 
of the various nuclei sum together to form a single vector in the direction of B0 
(Cavanagh et al. 2010).  To observe the nuclear magnetization we must force the 
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magnetization perpendicular to B0.  This is achieved by applying a radio pulse with the 
same frequency as the Larmor precession (Cavanagh et al. 2010).  After the pulse, the 
nuclear magnetization vector will then be perpendicular to the external magnetic field 
and the angular rate of rotation will induce an electric current which can be measured in 
a receiver coil surrounding the sample (Hore et al. 2000).  Over time the perpendicular 
magnetization will decrease as the magnetization relaxes to align with B0 (Cavanagh et 
al. 2010).  Thus, the amplitude at the receiver coil will decrease over time and provide a 
measurement known as the free induction decay, or FID (Figure 13; Hore et al. 2000).   
By applying a Fourier transform (FT) to the FID one is able to deconvolute the FID 
into a dataset that resolves the resonance frequencies for individual nuclei (Cavanagh et 
al. 2010).  The NMR active nuclei of the molecule exist in different chemical 
environments and thus can be distinguished from one another by their characteristic 
chemical shifts (Cavanagh et al. 2010).  In the work described herein, we are exploiting 
the fact that changes in the local chemical environment, such as protein-substrate 
binding, are associated with changes in the local magnetic environment of a given 
nucleus. This is manifested as a change in the chemical shift for that nucleus, and is the 
key piece of information needed to map which atoms in the protein are likely involved 
in substrate binding. 
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Figure 13:  NMR data workflow. Image generated by Dr. Serge Smirnov at Western 
Washington University, Department of Biochemistry.   
 
Figure 14 shows a one-dimensional (1D) spectrum of 1H resonances for the 76-
residue peptide ubiquitin. As is evident from Figure 14, there is substantial overlap in 
the resonances of the 629 1H nuclei in ubiquitin in a 1D NMR spectrum, making the 
resolution of individual resonances impossible. To achieve resolution of these signals so-
called multi-dimensional experiments are necessary.  
 
  
19 
 
 
Figure 14: 1D 1H-NMR spectrum of the small protein ubiquitin. The spectrum was 
acquired on a 500 MHz instrument. The ranges of chemical shifts for aliphatic, aromatic, 
and amide protons are indicated. Mathews et al. “Biochemistry 4th edition”, pg 225. 
To perform a multi-dimensional experiment it is necessary to enrich the protein 
in the NMR-active nuclei 15N and/or 13C, both of which are present in low natural 
abundance.  Figure 15 shows the amide 1H resonances for ubiquitin resolved in a two 
dimensional NMR experiment (15N-HSQC) that records individual 1H spectra as a 
function of 15N chemical shift.  The individual backbone amide 1H resonances can be 
completely resolved using this approach. For larger proteins there may be overlap of 
resonances in the 15N HSQC. Individual resonances can then be resolved by collecting a 
3D dataset which includes a series of 15N HSQC spectra recorded as a function of 13C 
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chemical shift. Such 3D datasets are also need to assign the individual resonances in the 
HSQC spectrum to particular amino acids in the protein sequence. 
 
Figure 15: Display of 2D Protein NMR experiment.  Due to the complexity of proteins it is 
necessary to utilize multi-dimensional experiments.  A proton spectrum is collected at 
each nitrogen shift.  If compiled together into a single proton spectrum the amount of 
data is overly convoluted.  By working with the data in two dimensions it is possible to 
resolve the peaks and gain valuable information for each residue.  Most commonly this is 
imaged from the top down as a topographic map as shown in Figure 16.  Mathews et al. 
“Biochemistry 4th edition”, pg 226 (Figure generated by S. Smirnov).   
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Figure 16: 2D NMR top down “topographical” map view of a standard NHSQC where 
each spot is a peak from the two dimensional spectrum.  Mathews et al. “Biochemistry 
4th edition”, pg 226 (Figure generated by S. Smirnov).   
 
The changes in the chemical environment of the protein upon binding of a 
specific substrate lead to changes in the positions and intensities of peaks in the HSQC 
spectrum (Cavanagh et al. 2010).  Depending on the relative rates of ligand binding and 
NMR data acquisition, the changes to the peaks in the HSQC spectrum will be observed 
in different ways.  If the association of the protein and its ligand occurs faster than the 
NMR acquisition time, a shift in the peak is observed (Hole et al. 2000).  If instead the 
rates of ligand binding and release occur on the same timescale as the NMR acquisition 
time, peak broadening will be observed (Hole et al. 2000).  Finally, if the ligand 
binding/release is slower than the NMR acquisition time, a peak doubling will occur 
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(Hole et al. 2000).  The changes in peak position and/or intensity can be used to map the 
sites on the protein that are most affected by ligand binding. 
For an NMR investigation of the interaction between an enzyme which cleaves 
its substrate, such as Tae1 and peptidoglycan, it is necessary to inhibit the activity of the 
enzyme to allow for NMR data collection on a homogenous sample. (Cavanagh et al. 
2010).  If Tae1 maintains its amidase activity then the interaction between Tae1 and PG 
will be over too quickly for observation by NMR.  To get around this problem a point 
mutation was made which inactivates the enzyme by replacing the essential cysteine 
nucleophile with alanine. This mutation does not otherwise effect the structure of the 
protein (Vivian et al. 2003). Unfortunately, this mutation did not facilitate the co-
crystallization of Tae1 with PG fragments. Nevertheless, we hope to use NMR to 
determine which residues in Tae1 are responsible for PG binding. 
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Methods 
 Tae1 containing a C-terminal hexahistidine tag was expressed and purified as 
described (Chou et al. 2012). Briefly, soluble protein was isolated from clarified lysate by 
metal affinity chromatography followed by size-exclusion chromatography 
 
 PG fragments were isolated from B. subtilis.  Both liquid media and plate growth 
were attempted to determine best method for bacterial production.  For plate growth B. 
subtilis seed stock was inoculated on rich plate media and held in a constant 
temperature incubator overnight.  Subsequently the bacterial colonies were scraped off 
of the plates with a glass stir rod and ice cold saline and collected in a flask.  Liquid 
media growth was performed in LB medium inoculated with B. subtilis seed stock and 
held overnight in a constant temperature shaker.   
In both cases once the growth was complete bacterial cells were harvested by 
high speed centrifugation with two washes of cold sodium chloride solution, one of 
water, and three final washes with acetone.  Subsequently the washed cell pellet is 
dried at 37⁰C.  The dried bacterial cells are then suspended in ice-cold water and 
transferred to 2mL “bead beater” tubes containing roughly five 0.10-0.15mm glass 
beads.  These samples are then treated in a bead beater for four two-minute intervals 
for a total of 8 minutes with cooling on ice for 6 minutes in between rounds.  The 
mixture of broken cells and glass beads is filtered. The cell walls are then separated from 
the supernatant by ten minutes of centrifugation at 1500 x g and 4 ⁰C.  The pelleted cell 
walls were washed three times with water, and then resuspended in 200 mL of pH 7.6 
phosphate buffer.  To this suspension RNase A was added to a final concentration of 100 
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µg/ml, DNase to a final concentration of 50 µg/mL, along with 0.5mL toluene.  This 
mixture was then incubated at 37 ⁰C for 18hr at which point sterile trypsin was added to 
a final concentration of 200 µg/ml and incubated for a further 18 hours at 37⁰C.  After 
the final incubation period the cell walls were pelleted by high speed centrifugation as 
described above, washed three times with water, and finally lyophilized. 
 NMR data was collected on a 500 Mhz Bruker instrument in the lab of Rachel 
Klevit. Data was processed with NMRpipe using scripts provided by Dr. Peter Brzovic. 
 NMR assignment was performed utilizing the “NMRviewJ” software suite from 
One Moon Scientific. Assignments of backbone amides in the NHSQC spectrum, were 
carried out by analysis of data from HCONH, HNCACB, HNCB, and HCCONH experiments. 
For the side chain assignments, HCCH COSY and HCCH TOCSY peaks were individually 
peak-picked and assigned by hand.  Multiple attempts were made to achieve the best 
assignment possible for the CHSQC using combinations of the ppm assignments from 
the previously assigned side chain experiments.  Side chain assignments were checked 
against average values from the Biological Magnetic Resonance Bank (BMRB; 
http://www.bmrb.wisc.edu/).  This initial assignment was checked further utilizing the 
NMRviewJ “atom assign” tool.  Each assignment was also checked against the X-ray 
crystal structure to make sure that the proposed assignments fell within established 
ranges for a given residue in the context of the predicted secondary structure. 
 A typical assignment workflow requires working through a single sidechain at a 
time, cross-referencing the paired experiments (i.e., HCCH TOCSY and HCCH COSY) to 
make sure that the assignments match.  Due to the high number of shared resonances 
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between similar amino acid side chains it was helpful to resolve these shared 
resonances by comparing residue assignments with the location found in the X-ray 
crystal structure and against BMRB standards.  A typical assignment for a single side 
chain can take several hours to complete.  For the NMR titration analysis, the changes in 
peak intensity for each resonance are graphically compared, normally after their overall 
change has been normalized to one, as observed in Appendices 4 and 5. 
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Results 
 The initial characterization of Tae1 assigned 89.2% of the backbone amides and 
87.4% of side chains, Figures 17-20.  Factors that limit the completion of assignments 
include the absence of peaks for prolines, and the inability to differentiate between 
reciprocal/mirror-imaged systems (such as the two delta carbons and 6 delta hydrogens 
found in Leucine). In these cases, the peak in the spectrum was labeled with a shared 
assignment.  Of the non-assigned residues displayed in grey in figures 17 and 18, there 
are six proline residues, furthermore the unassigned active site proximal extension is 
composed of Thr88 and Tyr89, and the unassigned residue to the far right of  the 
catalytic His91is Arg132.  As the backbone assignments are necessary for sidechain 
assignment, the percentage of residues with backbone assignments represents the 
upper limit of what can be achieved for sidechain assignments.  Therefore, 87.4% side 
chain assignments represents a nearly full coverage of all assignable sidechain residues 
in NMR experiments.  These assignments set the stage for investigating the binding of 
Tae1 with Hcp1 and peptidoglycan. 
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Figure 17: Pymol image of Tae1 with assigned backbone residues colored in green, and 
unassigned residues colored in grey.  Catalytic residues Cys 30 and His 91 colored red 
and yellow respectively 
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Figure 18: Pymol image of the backside of Tae1 with assigned backbone residues colored 
in green, and unassigned residues colored in grey. 
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Figure 19: Pymol image of Tae1 with assigned side chain residues colored in green, and 
unassigned residues colored in grey.  Catalytic residues Cys 30 and His 91 colored red 
and yellow respectively 
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Figure 20: Pymol image of the backside of Tae1 with assigned side chain residues colored 
in green, and unassigned residues colored in grey 
 
After the assignment of the backbone amides for Tae1 an NMR titration was 
performed by incubating 15N-labeled Tae1 with increasing concentrations of Hcp1 
(Figure 21) and the non-binding Hcp1 mutant S115Q, with the expectation that the 
addition of increasing wild type Hcp1 would affect certain Tae1 resonances, whereas the 
S115Q mutant would not show any effect (Silverman et al. 2013).   As can be observed 
in figure 22 and 23 there were little to no observable changes in the spectra through the 
series of the titrations.  Shown in Appendix 4 and 5 are the graphical analyses of the 
titrations which show that the only quantitative change is a decrease in overall spectral 
intensity as a function of increasing concentrations of Hcp1.  
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Figure 21: NHSQC overlay of Tae1 titration with Hcp1.  The red box displays the region of 
the spectrum utilized in Figures 22 and 23 
 
 
Figure 22: Representative panels from NHSQC titration of Tae1 with increasing 
concentrations of Hcp1 
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Figure 23: Representative panels from NHSQC titration of Tae1 with increasing 
concentration of Hcp1 mutant S115Q. 
 
To explore binding of Tae1 with it’s putative substrate Tae1 titrations with a 
muropeptide containing the L-Ala-D-Glu-mDAP crosslink within a series of 9 residues 
with a single GlcNac moiety bound to the muropeptide known as the “tetra-tetra” 
fragment of PG (see figure 24) were also performed, but yielded no evidence for specific 
binding.  
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Figure 24: NHSQC overlay of Tae1 (black) and Tae1 incubated with tetra-tetra fragment 
(displayed in upper left corner of the spectrum) of PG (teal).  Spectra collected by Drs 
Seemay Chou and Jonathan Pruneda at University of Washington. 
  
 
Figure 25: CHSQC of Tae1 with the spectral region displayed in figure 26 highlighted in 
red. 
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  To generate side chain assignments, the CHSQC spectrum of Tae1 was assigned 
using the NHSQC assignments as well as C atom resonances observed in the following 
experiments: CCONH TOCSY, HCCONH TOCSY, HCCH COSY, and HCCH TOCSY.  Owing to 
the vast amount of information on the CHSQC spectrum it was extremely difficult to 
resolve assignments for individual residues, however 70% of the peaks could be 
assigned, as shown in Appendix 2.   This provided coverage of at least a portion of the 
protons for every single side chain residue that could be assigned (e.g., Pro residues are 
not assignable).  While not every proton for each side-chain could be assigned, the 
spectral coverage of Tae1 in side chain displaying experiments is very robust.   
Upon incubation of triple-labeled Tae1 with intact sacculi we observed several 
peaks disappearing from the spectrum.  To investigate the role of the glycan strand in 
the binding, Dr. Chou subsequently incubated this sample with lysozyme.  Interestingly 
when a CHSQC spectrum was collected, all of the peaks that disappeared returned 
following the lysozyme treatment (Figure 26).   
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Figure 26: CHSQC spectra of Tae1 (black), Tae1 incubated with whole sacculi (red), and 
Tae1 incubated with whole sacculi then with lysozyme (blue) 
 
 
 
 
Discussion 
 The experimental approach that we took for this project was the application of 
NMR to investigate the binding of the toxic amidase effector Tae1 with potential 
regulatory factor Hcp1 and Tae1’s PG substrate.  Our objective was to identify the 
residues of Tae1 which are responsible for determining the apparent specificity of PG 
cleavage by Tae1. 
Standard NHSQC-based NMR titration experiments of PG fragments with Tae1 
have not yet yielded any evidence that explains the apparent cleavage specificity of the 
amidase. Nor does Tae1 appear to bind Hcp1 with any specificity. Hcp1 had been shown 
to bind a different effector based on EM analysis, and given the role of Hcp1 in the 
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assembly of the secretion apparatus, we hypothesized that Tae1 would also associate 
with Hcp1 (Silverman et al. 2013). 
The only evidence for binding in NHSQC-based experiments was observed at low 
pH (pH 5.0) for a side chain amide (Figure 24). We therefore turned to CHSQC 
experiments to probe the details of Tae1 side chain interactions with putative 
substrates. 
CHSQC titrations show that the addition of intact sacculi results in the 
disappearance of several peaks; however, these peaks also showed a small signal to 
noise ratio prior to addition of the sacculi. Thus, differential effects on peak intensity of 
chemical shift were impossible to discern in this experiment. Interestingly, these peaks 
returned upon addition of lysozyme to this sample. 
This result suggests that the glycan strand must be intact for Tae1 to bind. If this 
is true, it would explain the lack of specific interactions in the NHSQC titration 
experiments using PG fragments (in which the glycan portion was absent). Lysozyme 
cleaves PG between the GlcNac (NAG) and MurNac (NAM), but leaves the peptide 
region intact.  We theorize that the binding affinity of Tae1 for PG is greater when the 
glycan strand is intact; however, it is unclear how (if at all) the glycan affects Tae1 
cleavage specificity for the peptide portion of PG. 
Intact sacculi are too large to allow us to probe specific interactions with Tae1 
via NMR.  PG fragments of defined size that include intact NAG-NAM bonds would be 
more amenable to NMR analysis; however, such fragments are not produced by the 
methods commonly used to generate PG fragments from sacculi.  
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Chemical synthesis has been used to generate defined PG fragments with intact 
glycan bonds.  This method was utilized by Mellroth et al. however, this necessitated a 
thirty step synthesis which would be cost prohibitive for NMR-based investigations 
(Mellroth et al. 2014).   
To generate appropriately sized PG fragments we have attempted fragmentation 
of purified PG sacculi through a combination of sonication and limited digestion with 
lysozyme.  While this has not yet yielded the desired fragments, a future goal is to 
optimize this process to generate fragments of appropriate size and composition for 
NMR experiments. 
 
Figure 27:  Cartoon representation of minimal binding fragment generation/isolation 
experiment theory.  By utilization of stepwise addition of Lysozyme or sonication the goal 
will be to isolate fragments of a size small enough that they don't completely obscure 
the signal in NMR experiments as seen with intact sacculi, but with the necessary size 
and complexity that binding can occur and be observed. 
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In collaboration with the Vollmer lab, sacculi which have been treated with a 
muramidase (e.g., lysozyme) will be subsequently treated with catalytically active, wild-
type, Tae1.  As displayed in appendix 6, based on the results shown in Figure 10, we 
expect that this order of addition, muramidase then Tae1, will lead to reduced cleavage 
of the peptide portion of the PG.  If significant cleavage of the PG peptides is observed 
in this experiment we would then need to examine whether the active site Cys to Ala 
mutation has impaired Tae1 binding to PG fragments compared to wild-type Tae1.  The 
data in Figure 26 suggest that the presence of glycan strands in the PG fragments is 
required for Tae1 binding.  A similar observation was reported by Mellroth et al. for the 
pneumococcal autolysin LytA (Mellroth et al. 2014).  They found that having a GlycNac 
on both sides of the muropeptide was necessary for cleavage of PG by LytA. 
Furthermore, the cleavage of this PG fragment was reduced compared to cleavage of PG 
fragments with longer glycan strands.  Upon further study, as reported in a recently 
released paper in press, Mellroth et al. successfully co-crystalized LytA with a large PG 
fragment (diGM5P) spanning four GlcNac/MurNac alternating residues linked to an L-
Ala-D-Glu-L-Lys-D-Ala-D-Ala pentapeptide (Sandalova et al. 2016).  This result supports 
our hypothesis of the necessity of a larger PG fragment for experimentally observable 
binding.   
Solid state NMR (ssNMR) is a powerful technique which has been utilized in the 
study of PG and provided the first atomic model of an enzyme in complex with an intact 
bacterial PG sacculus (Schanda et al. 2015).  Because of the size and dynamic nature of 
PG it is challenging to analyze large PG fragments via solution state NMR or X-ray 
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crystallography. Solid state NMR may be a useful method for future investigations of 
Tae1 interactions with larger PG fragments, however, the low sensitivity of ssNMR is of 
concern; while experiments showed effects within the PG from the binding of an L-D-
transpeptidase from B. subtilis bound to its PG substrate the technique lacked the 
sensitivity required to determine atomic detail of the interaction of the protein itself 
(Schanda et al. 2015). 
The challenges associated with the production/isolation of a suitable PG 
substrate of Tae1 have limited our ability to determine the atomic-level details of Tae1 
binding to PG. However, our assignments of both the backbone and sidechain residues 
in Tae1 will allow for such determination as soon as a minimal binding fragment of PG 
can be isolated and characterized.  Future work will be necessarily focused on 
development of such a minimal binding PG fragment.   
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Appendix 1: Residue assignments for Tae1 in NHSQC, HCACB, CCONH TOCSY, and HCCONH TOCSY Experiments 
Protein NHSQC HCACB CCONH HCCONH 
Res  Num       H       N     CA     CB CA CB CG CG2 CD HA HA2 HB HB2 HG HG2 HD HD2 HE 
MET 1      --      --     --     --                             
ASP 2      --      -- 54.991 41.744 54.474 41.504       4.69   2.72 2.56           
SER 3 8.477 115.399 58.452 64.495 58.107 64.797       4.59875   3.95954             
LEU 4 8.858 126.106 55.583 42.069 55.448 41.801       4.49136   2.88679   1.5647   0.84878     
ASP 5 8.15 114.38 54.174 40.562 54.110 40.286       4.6184   3.00162             
GLN 6 8.023 122.191 60.231 28.186 59.968 28.021 33.984     3.82711   2.10604   2.40331         
CYS 7 8.459 116.846 61.559 35.703 61.659 35.498       4.67705   3.45002 3.0081           
ILE 8 7.464 126.476 64.75 39.048 64.744 38.831 29.150 18.082 13.488 5.37467   3.71812   2.12487 1.72471 0.92207     
VAL 9 8.15 122.258 68.065 32.021 67.806 31.839 23.123 21.776   3.11208   2.03669   1.0394         
ASN 10 8.736 117.342 56.382 37.813 55.880 37.527       4.26073   2.72322             
ALA 11 7.162 121.985 55.287 18.806 54.722 18.597       4.24875   1.45162             
CYS 12 8.211 120.877 64.055 25.658 63.741 25.423       3.68836   2.30153 1.11445           
LYS 13 7.975 119.047 60.233 32.683 59.946 32.426 25.971     3.7635   1.80569   1.32812   1.53205   3.04538 
ASN 14 8.207 116.238 55.278 38.816 55.556 38.489       4.53071   2.9785 2.76335           
SER 15 7.878 113.896 61.468 64.107 61.196         4.1722   3.74287 3.52298           
TRP 16 8.017 124.298 61.414 31.464 61.262 31.240       4.45729   3.86148 3.50156           
ASP 17 7.918 111.341 54.733 42.171           4.83736   2.9922 2.61317           
LYS 18 7.125 119.195 56.347 35.608 56.347                           
SER 19      --      -- 56.648 64.416 56.347         4.54131   3.61572             
TYR 20 8.987 127.628 62.765 39.855   39.625       3.79315   2.40576             
LEU 21 8.07 118.561 52.985 42.906 52.813 42.633 27.008     4.28742   1.55654   1.43385   0.89242     
ALA 22 8.212 126.765 54.476 19.694   17.753       3.89807   1.27652             
GLY 23 8.599 111.624 45.809     -- 45.514         4.19563 3.69123               
THR 24 8.33 118.237 59.67 71.438                             
PRO 25      -- 123.119 63.261 32.963 63.106 32.821 27.855     4.46652   2.27885 2.04241 1.80369   3.80493     
ASN 26 9.156 123.154 55.662 37.701           4.44677   3.35868 2.58078           
LYS 27 7.548 116.213 58.558 30.28           4.73406   1.46687   0.94232 0.67041 0.20659   2.8602 
ASP 28 7.289 118.843 53.575 42.746 53.526 42.438       4.90088   2.9686             
ASN 29 7.327 116.395 52.808 40.542 52.659 40.267       4.70873   2.82526 2.56351           
ALA 30 9.119 127.538 56.984 21.329   21.085       4.12611   1.91277             
SER 31 8.582 111.651 61.111 62.67 60.799         4.13514   3.70235             
GLY 32 7.248 111.14 48.169     --           4.19563                 
PHE 33 8.342 118.522 63.208 38.556 63.140 38.289       3.98943   3.3406 3.08377           
VAL 34 7.22 116.465 67.556 31.668 67.120         3.06404   1.86513   1.12695         
GLN 35 8.363 118.109     --     --                             
SER 36 8.42 118.362 64.025 62.569 64.025             3.85192             
VAL 37 7.613 125.241 67.708 32.121 67.346 31.780       3.05024   1.81217   0.69161 0.29578       
ALA 38 8.284 119.717 55.854 18.53 55.354         3.65339   1.45397             
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ALA 39 8.009 119.157     -- 18.114   17.852       4.13455   1.5553             
GLU 40 7.852 120.307 59.711 29.289 59.555 29.449 36.325     3.96569   2.06063   2.22128         
LEU 41 7.436 115.601 55.071 43.526 54.723 43.171 28.608     4.21846   1.65782   1.66927   0.78635     
GLY 42 7.912 110.459 46.589     --           3.99067 3.7851               
VAL 43 8.154 124.097 59.7 34.29                             
PRO 44      --      -- 63.136 31.914 62.937 31.800 27.559     4.27804   2.20319   1.95389   3.49628     
MET 45 7.96 122.777 51.1 35.112                             
PRO 46      --      -- 63.181 32.639 62.984 32.639 27.197     4.33287   2.32139   1.61525         
ARG 47 8.038 120.031 55.893 32.283 55.668 31.990 27.429   43.484 4.23827   1.70585   1.70585   3.2054     
GLY 48 7.978 106.298 44.357     -- 44.256         4.41018 3.65941               
ASN 49 7.848 115.2 51.883 38.12           4.30089   3.54008             
ALA 50 8.398 119.176 56.94 18.544 56.940 18.293                         
ASN 51 8.204 116.394 56.1 37.484 56.002 37.291       4.41721   2.81998             
ALA 52 7.862 122.031 55.028 18.479 55.214 18.272       4.12574   1.5155             
MET 53 8.973 120.368 60.215 33.527 59.903         3.43528   1.96741   2.23854       1.69152 
VAL 54 8.152 119.353 68.115 31.042 67.893 30.888       3.0813   2.02515   0.96654         
ASP 55 7.668 117.935 58.173 40.475 58.088 40.194       4.31126   2.70982 2.55045           
GLY 56 7.886 106.567 47.359     -- 47.069         3.87926 3.40324               
LEU 57 8.586 127.345 58.195 39.162                             
GLU 58      --      -- 59.312 29.272 59.069 29.272 35.395     4.05312   2.1219   2.34787         
GLN 59 7.176 113.464 57.518 29.847 57.369   33.927     4.30103   2.19481   2.52359         
SER 60 7.695 110.005 60.54 67.061 60.203         4.97129   4.02243             
TRP 61 9.435 126.188 57.291 30.829                             
THR 62 8.389 118.896 64.289 70.212 64.093     21.761   4.25978   4.04431   1.12968         
LYS 63 8.683 127.093 55.934 34.252 55.550 33.948       5.12804   1.78238   1.38951   1.38951   2.9802 
LEU 64 8.751 124.258 53.362 44.021 53.203 43.723       4.58268   1.55564       0.68609     
ALA 65 8.776 120.673 54.026 20.38   20.119       4.34552   1.45702             
SER 66 7.138 106.868 56.858 66.729           4.83417   4.0317             
GLY 67 8.836 110.291 46.115     --           3.56359 2.70438               
ALA 68 8.118 124.097 55.337 18.211   17.996       3.9992   1.29481             
GLU 69 7.764 119.592 59.336 30.463 59.145 30.651 37.406     3.91654   1.99624   2.23641         
ALA 70 7.498 121.645 55.515 19.588   19.315       3.77275   1.12193             
ALA 71 7.795 119.034 55.464 19.316   19.018                         
GLN 72 7.582 117.638 59.099 28.559 58.752 28.704 33.889     4.06773   2.13399   2.39276         
LYS 73 8.198 118.718 57.748 31.056 57.527 30.853       4.11905   1.9299   1.42129   1.16373   2.45428 
ALA 74 8.247 125.013 55.55 17.988   17.729       5.05448   1.45125             
ALA 75 7.904 117.944 54.747 18.507 54.649 18.262       4.15769   1.66571             
GLN 76 7.59 116.341 56.002 29.693 55.807 29.015 34.266     4.39819   2.50602   2.7154         
GLY 77 8.277 106.739 46.292     -- 46.194         4.10221 3.50777               
PHE 78 7.801 118.747 57.862 41.505 57.417 41.246       4.722   2.66342             
LEU 79 9.745 123.944 55.224 42.117 54.927 41.847       4.61736   2.13382   1.71498   1.12089 0.94393   
VAL 80 9.822 129.925 60.731 34.566 60.488 34.356       5.4048   2.16219   1.03043         
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ILE 81 9.6 126.565 56.788 40.088 56.526 39.740 28.128 17.237   5.36585   1.94094   1.68937 1.04515 0.78128     
ALA 82 9.249 129.236 49.527 21.847   21.595       5.4477   1.23719             
GLY 83 9.006 106.733 46.53     -- 46.413                           
LEU 84 8.137 122.212 55.743 46.268 55.626 46.113       4.57225   1.79818   1.25307   0.88434 0.7021   
LYS 85 9.105 130.354 58.366 33.184 58.131 32.931 26.126     4.64234   1.63949   1.40487   1.05385   2.76264 
GLY 86 8.688 108.723 43.835     --                             
ARG 87 8.07477 131.638     --     --           4.3509   1.73781       3.24883     
THR 88      --      --     --     --                             
TYR 89      --      -- 57.031 40.832 57.195 40.593       4.86314   3.31133 3.06416           
GLY 90 8.674 111.011 44.754     -- 44.666         4.50977 3.87196               
HIS 91 8.06 115.87 57.748 33.577   33.299       4.87675   2.9214             
VAL 92 5.791 115.395 58.546 37.656 58.216 37.381       5.73063   1.90775   0.86316 0.66108       
ALA 93 9.267 121.566 51.427 24.519 50.548 24.239       4.85868   1.35962             
VAL 94 9.358 122.332 62.863 34.449 62.616 34.136       4.69736   2.37228   1.08082 0.89695       
VAL 95 9.018 129.916 63.529 32.489 63.257 32.360       4.48127   1.99259   1.18665 0.98276       
ILE 96 7.787 117.645 59.294 41.46 59.092 41.357       4.88934   2.21985   1.44531 1.0209 0.75009     
SER 97 8.71 114.369 59.112 64.491 58.764         4.33343   3.95279 3.74295           
GLY 98 7.874 109.356 44.589     --                             
PRO 99      --      -- 63.198 32.338   32.085 27.386     4.2756   2.25379   1.89207   3.59609     
LEU 100 8.094 118.082 54.213 42.102 54.004 41.763       4.1586   1.6435   1.39482   0.58535     
TYR 101 9.197 129.032 58.404 39.137   38.884                         
ARG 102      --      -- 57.129     -- 57.063       43.292 3.67045   1.95628 1.59009 0.69057   2.91785     
GLN 103 7.774 106.98 58.821 27.446           3.61535   2.27979             
LYS 104 7.327 116.413     --     --                             
TYR 105      --      --     --     --                             
PRO 106      --      -- 63.178 34.414 62.911 34.240 27.941     4.67818   2.1568   1.96814   2.50043     
MET 107 9.417 120.069 54.741 30.659 54.411         4.68092   1.81988   2.76585         
CYS 108 8.052 110.77 56.83 34.421 56.605 34.156       6.26065   2.87336             
TRP 109 9.61 120.696 57.11 34.203 56.871 33.886       5.03618   3.60476 3.33425           
CYS 110 9.415 113.804 56.993 30.946   30.677       5.12075   3.41935             
GLY 111 7.737 107.733 43.575     -- 43.146         4.4355 3.55262               
SER 112 8.205 107.524 59.863 65.268           4.49356   4.07778 3.24877           
ILE 113 8.955 133.45 62.513 38.58 62.351 38.302 28.938 16.218 14.162 4.14994   1.85346   1.45267 1.18735 0.75376 0.54783   
ALA 114 8.409 124.196 52.778 18.948   18.677       4.10093   1.16481             
GLY 115 7.413 105.563 44.355     -- 44.223         4.25446 3.66678               
ALA 116 8.496 124.61 55.923 18.745 56.119 18.535       3.93664   1.39756             
VAL 117 7.918 112.732 64.609 31.678 64.376 31.410       3.81068   2.02281   0.81251         
GLY 118 7.562 107.192 44.571     -- 44.506         4.10107 3.28174               
GLN 119 6.977 117.521 54.728 31.268 54.422   33.613     4.34257   2.14151   2.74711         
SER 120 8.866 112.118 57.261 65.003 57.008         4.40856   3.16622             
GLN 121 8.48 131.034 52.175 28.089 52.100   33.269     2.69445   -0.00026   0.81986         
GLY 122 5.981 104.739 45.651     --           3.54682 3.01138               
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LEU 123 6.272 114.225 54.721 43.353   42.968       3.81711   1.56007   1.20945   0.70934     
LYS 124 7.581 117.832 54.316     -- 54.316         4.49136   1.5647   1.19173         
SER 125 8.151 113.669 56.799 67.693   67.349       4.10652   3.61312             
VAL 126 9.397 117.672 65.012 31.237 64.760 31.089       4.51251   2.80803   1.30241 1.46771       
GLY 127 7.96 103.673 45.842     -- 45.580         3.78418 2.72885               
GLN 128 7.485 116.226 56.462 32.455 56.190   35.090     4.43083   1.79036 1.25345 2.22798         
VAL 129 7.106 114.632 64.113 32.78 63.783 32.631       3.94528   1.88867   0.77523 0.42237       
TRP 130 7.375 119.77 59.913 31.222   31.070       4.6289   3.15939 2.94091           
ASN 131 9.094 116.291 52.336 38.688                             
ARG 132      --      -- 59.647 30.485 59.647 30.485       3.69882   1.85689   1.64613   3.21803     
THR 133 7.879 113.89 64.751 69.186 64.384     21.923   4.20772       1.20095         
ASP 134 8.595 123.629 57.154 41.066           4.28281   2.56388             
ARG 135 8.505 114.648 58.693 29.274 58.434 29.223       3.64535   1.83315   1.46152   2.64322     
ASP 136 7.182 117.118 55.297 41.449           5.24888   3.12372 2.53614           
ARG 137 7.885 119.436 55.311 31.028 55.098       43.765 4.56841   1.89373   1.64485   3.22938     
LEU 138 6.234 115.501 55.605 42.805 55.288 42.552       3.38678   1.07475   0.18509   -1.07008     
ASN 139 7.068 116.088 51.739 43.582           4.68121   2.60922 1.74593           
TYR 140 8.645 119.17 56.923 41.79 56.565 41.515       5.05283   2.59112 2.39688           
TYR 141 9.452 123.016 56.79 42.347 56.672 42.139       5.55639   3.22528 2.78493           
VAL 142 9.492 122.153 58.914 36.505 58.719 36.242       5.72828   1.79202   1.06855 0.79661       
TYR 143 7.816 129.667 58.023 37.387           5.35775   3.31256             
SER 144 8.397 118.6     -- 63.451           3.88587   3.51897             
LEU 145 6.377 120.425 53.739 45.673           4.58963   1.46184   0.8526         
ALA 146 8.36 125.723 53.263 17.813   17.534       3.06241   0.61941             
SER 147 8.403 119.781 61.406 65.568 61.180         4.57994   3.89997 3.49345           
CYS 148 7.931 118.222 52.872 38.352 52.821 38.154       5.06153   3.76573 3.14869           
SER 149 8.352 115.443 57.906 65.347 57.468         4.51948   3.76201             
LEU 150 8.283 124.408 53.553 42.246                             
PRO 151      --      -- 63.465     -- 63.212       50.764 4.4233   2.28373   1.94249   3.87214 3.64175   
ARG 152 8.394 121.773 56.285 31.299           4.30108   1.85722 1.65319 1.39821   3.21038     
ALA 153 8.003 131.465     --     --           4.36314   1.40854             
SER 154 7.929 121.011     --     --                             
LEU 155      --      --     --     --                             
GLU 156      --      --     --     --                             
HIS 157      --      --     --     --                             
HIS 158      --      --     --     --                             
HIS 159      --      --     --     --                             
HIS 160      --      --     --     --                             
HIS 161      --      --     --     --                             
HIS 162      --      --     --     --                             
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Appendix 2: Residue Assignment for Tae1 in HCCH COSY and HCCH TOCSY Experiments 
    HCCH COSY Assignments HCCH TOCSY Assignments 
Residue 
#   Ha1 Ha2 Hb1 Hb2 Hg1 Hg2 HCD1 HCD2 HCE1 HCE2 Ha1 Ha2 Hb1 Hb2 Hg1 Hg2 HCD1 HCD2 HCE1 HCE2 
1 met                                         
2 asp 4.563     2.640             4.714   2.747 2.569             
3 ser 4.577     3.956             4.579   3.953               
4 leu 3.367     -0.227 0.943   -0.041 -0.036     3.367   0.757   0.957   -0.039 -0.039     
5 asp 3.620   2.267               4.604   3.300 3.073             
6 gln 3.838   2.340   2.350           3.826   2.041   2.425           
7 cys 4.660   3.442 3.003             3.642   2.263               
8 ile 3.762   2.110   1.116 0.928         3.743   2.132   1.108 0.935         
9 val 3.115   2.026   1.059           3.104   2.035   1.053           
10 asn 4.281   2.734                                   
11 ala 3.903   1.316               3.896   1.270               
12 cys                                         
13 lys 4.307   0.958   0.917   1.418   2.885   4.298   0.888 0.216 0.853   1.420   2.885   
14 asn 4.555   2.995 2.782             4.538   2.978   2.759           
15 ser 4.445   3.852               4.463   3.846               
16 trp                                         
17 asp 4.854   3.106 2.652             4.866   2.993 2.624             
18 lys 3.749   1.805   1.536   1.718   2.989   3.745   1.816   1.536   1.722   3.033   
19 ser 4.546     3.628             4.541   3.612               
20 tyr 3.846   2.426               3.813   2.444               
21 leu             0.310                   0.310       
22 ala 3.889   1.275               3.888   1.270               
23 gly 4.177 3.686                 4.200 3.682                 
24 thr                                         
25 pro                                         
26 asn 4.412   2.811               4.419   2.814               
27 lys                                         
28 asp 4.949                   4.913                   
29 asn 5.054   3.768 3.177             5.055   3.708 3.144             
30 cys30ala                     4.250   3.177               
31 ser 4.965   4.077               4.940   4.077               
32 gly                     3.702 3.545                 
33 phe 4.672   2.326               4.660   2.442               
34 val                                         
35 gln                                         
36 ser 4.129     3.841             4.151   3.845               
37 val 3.060*   1.818   0.083           3.093   1.807   0.721           
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38 ala 3.942   1.394               3.945   1.394               
39 ala 4.124   1.542               4.119   1.540               
40 glu 4.038     2.150 2.618? 2.572?         3.960   2.252 1.993 2.112 2.097         
41 leu 4.330   1.505   1.513   0.689       4.332   1.478   1.193   0.703       
42 gly                     3.989 3.743                 
43 val 3.952   1.503   0.168           3.935   1.499   0.168 0.168         
44 pro 4.4175   2.278 1.8851 2.0113   3.846 3.6388     4.4806   2.2833   2.0288   3.8486       
45 met                     5.257   1.872 1.657 1.872 1.667         
46 pro 4.3288   2.278 1.6326 1.6369   3.6171 3.4745     4.2554   2.2929   1.7237   3.6222       
47 arg 4.230   1.679   1.649   3.193       4.236   1.747   1.678   3.198       
48 gly 4.383 3.629                 4.241 3.661                 
49 asn                         2.723               
50 ala 4.235   1.669               4.240   1.653               
51 asn                     4.262   2.714               
52 ala 4.134   1.505               4.341   1.443               
53 met 3.434   1.955 1.666 2.245 2.010         3.441   1.999 1.697 2.048 1.886         
54 val 3.1929*   2.009               3.078   2.015   0.819           
55 asp 4.611   3.043               4.310   2.708 2.541             
56 gly 3.893 3.387                 3.866 3.402                 
57 leu         1.661   0.689                           
58 glu 3.9185   1.9856   2.2586           3.9328   1.9867   2.3029 2.1686         
59 gln 4.292   2.189 2.196 2.5341* 2.5341*         4.285   2.246 2.139 2.522           
60 ser                     4.228   3.828               
61 trp                     4.070   2.458 2.347             
62 thr 4.276   4.057   1.149           4.261   4.057   1.125           
63 lys 5.100   1.780   1.379           5.112 1.775   1.353   1.780   3.030     
64 leu                     4.575   1.567   0.668   0.753 0.753     
65 ala 4.344   1.469               4.340   1.452               
66 ser                                         
67 gly 3.583 2.693                 3.573 2.680                 
68 ala 4.649   1.668               4.560   1.645               
69 glu 3.967   1.790   1.831           3.964   1.384   1.812           
70 ala 3.787   1.566               3.812   1.558               
71 ala 3.770   1.117               3.779   1.112               
72 gln                                         
73 lys 4.127   1.950   1.441 1.100 1.439 0.932 2.488 2.173 4.121   1.937 1.407 1.483 1.622 1.408 0.949 2.485 2.175 
74 ala 3.997   1.2822               3.967   1.268               
75 ala 4.178   1.664               4.164   1.657               
76 gln 4.371   2.018 2.043 2.348           4.314                   
77 gly   3.481                 4.084 3.498                 
78 phe 4.872   2.971               4.867   2.950               
79 leu 4.284   1.573   1.498   0.839       4.294   1.570   1.480   0.928 0.925     
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80 val     2.286   0.953               2.337   1.073           
81 ile 5.367   1.931   1.688 0.753 0.771       5.362   1.915   1.670 0.768 0.781       
82 ala                                         
83 gly 5.334 3.701                 5.359 3.655                 
84 leu 4.548       1.795   0.839       4.578   1.805   1.757   0.836 0.836     
85 lys                                         
86 gly 4.582 3.681                 4.589 3.730                 
87 arg 3.980   1.831   1.630                               
88 thr 4.217   3.920               4.215   3.957   0.994           
89 tyr                                         
90 gly 4.380 3.718                 4.589 3.934                 
91 his                     4.383   3.929               
92 val 5.7548   1.9246   0.8389           5.7259   1.89   0.8656 0.8656         
93 ala                                         
94 val 4.088   2.017   0.845           4.058   2.023               
95 val 3.965   2.026   0.836                               
96 ile 4.897   2.124   1.405   1.104       4.885   2.219   1.470   1.105       
97 ser 4.389     3.845             4.397   3.850               
98 gly 4.136 3.300                 4.451                   
99 pro 4.4175   2.2781 1.8885 2.0164   3.6027       4.2559   2.2747   2.1239   3.6207       
100 leu                     4.176   1.396   0.608   0.463 0.463     
101 tyr                     4.588   3.957               
102 arg                                         
103 gln 4.657   1.398   1.382           4.649   1.658   1.445           
104 lys 4.307   0.669   0.737   1.661   2.885   4.291   0.796 0.662 0.974 0.756 1.412 1.422 2.882 2.733 
105 tyr 4.262   2.679               4.221   2.727               
106 pro                                         
107 met                     4.035   2.093   2.500           
108 cys 4.448   3.175 3.175             4.398   2.720 2.502             
109 trp 4.564   2.979               4.552   2.999               
110 cys                     4.566   3.178 3.041             
111 gly 4.427 3.497                 4.441 3.557                 
112 ser 4.581     3.808             4.397   3.857               
113 ile 4.129   1.831   1.423   0.783       4.141   1.865   1.185 1.416 0.794     0.777 
114 ala 4.104   1.163                   1.610               
115 gly 4.415 3.660                 4.410 3.664                 
116 ala 4.217   1.439               4.251   1.465               
117 val 3.797   1.993   0.838           3.816   2.024   0.780           
118 gly 4.415 3.730                 4.097 3.284                 
119 gln 4.728                   4.033   2.601   2.124           
120 ser 4.495     3.783             4.517   3.757               
121 gln 3.807   2.026   2.378           3.793   1.793   2.303           
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122 gly                                         
123 leu 4.3409   1.3647   1.2076   0.7288       4.322   1.4941   1.1999   0.7278       
124 lys                                         
125 ser 5.320     4.089             5.321   4.117               
126 val                                         
127 gly 4.195 3.672                 3.523 3.002                 
128 gln                                         
129 val 3.937   1.857   0.732           3.963   1.882   0.431 0.821         
130 trp                     4.504   3.008               
131 asn 4.417   3.392 2.840             4.406   3.422               
132 arg 3.702   1.846   1.617   3.193       3.705   1.853 1.848 1.564   3.202       
133 thr 4.255   4.169               4.223   3.934   1.199           
134 asp 4.255   2.605               4.282   2.666 2.562             
135 arg                                         
136 asp 4.485   1.520               4.227   3.199               
137 arg 4.612     3.141                                 
138 leu 3.3957   1.0169   0.1513   -1.042       3.3847   1.1137   0.1607   -1.081       
139 asn                                         
140 tyr                                         
141 tyr                                         
142 val                                         
143 tyr 4.157   2.169               4.162   2.149               
144 ser                                         
145 leu                                         
146 ala                                         
147 ser                     4.566   3.963               
148 cys     2.998 2.754             2.976   2.748               
149 ser 4.384   3.852               4.396   3.853               
150 leu                                         
151 pro                                         
152 arg                                         
153 ala 4.286   1.379                                   
154 ser 4.393     3.845                                 
 
 
54 
 
Appendix 3: NHSQC Experiment with Assignments Shown 
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Appendix 4: CHSQC Experiments with assignments shown 
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Appendix 5: Graphical Comparison of NMR (NHSQC) peak intensity of WT-Tae1 Titration with Hcp1 
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 Appendix 6: Graphical Comparison of NMR (NHSQC) peak intensity of Tae1-S115Q Titration with Hcp1
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Appendix 7: Experimental Design for Confirmation of Tae1 Minimal Binding Fragment Specificity 
 
